RYLENTIX Trademark
RYLENTIX is a USPTO trademark filed by Abiogen Pharma S.p.A.. Status: Cancelled.
Trademark Facts
| Mark | RYLENTIX |
|---|---|
| Serial Number | 87510865 |
| Registration Number | 5754281 |
| Status | Cancelled |
| Filing Date | 2017-06-29 |
| Registration Date | 2019-05-21 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Abiogen Pharma S.p.A. |
| Attorney of Record | John O'Malley |
| Prosecution Events | 23 |
| Latest Event | C8.. on 2025-12-05 |
Goods & Services
Pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronate sodium; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronate sodium